282P Efficacy comparison of immune therapy combined with chemotherapy and radiotherapy versus traditional treatments in locally advanced unresectable esophageal squamous cell carcinoma

Locally advanced unresectable esophageal squamous cell carcinoma (ESCC) has a poor prognosis despite various treatment strategies. The combination of immune checkpoint inhibitors (ICIs) and radiotherapy has shown synergistic effects in cancer immunotherapy. This study aims to evaluate survival outcomes of different treatments for locally advanced ESCC, focusing on immune therapy combined with chemotherapy.

Authors

Institutions

Publication Details

Journal
Immuno-Oncology Technology
Published
2025-12-01
DOI
https://doi.org/10.1016/j.iotech.2025.101481
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

282P Efficacy comparison of immune therapy combined with chemotherapy and radiotherapy versus traditional treatments in locally advanced unresectable esophageal squamous cell carcinoma

Y. Zhang, H. Sun, H. Hong, Y. Yuan et al.
Immuno-Oncology Technology
Esophageal Cancer Research and Treatment
article

282P Efficacy comparison of immune therapy combined with chemotherapy and radiotherapy versus traditional treatments in locally advanced unresectable esophageal squamous cell carcinoma

Y. Zhang, H. Sun, H. Hong, Y. Yuan, Y. Qu
article en

Abstract

Locally advanced unresectable esophageal squamous cell carcinoma (ESCC) has a poor prognosis despite various treatment strategies. The combination of immune checkpoint inhibitors (ICIs) and radiotherapy has shown synergistic effects in cancer immunotherapy. This study aims to evaluate survival outcomes of different treatments for locally advanced ESCC, focusing on immune therapy combined with chemotherapy.

Immuno-Oncology TechnologyVol. 28
Genertec Shenyang Machine Tool Co., Ltd. (China) (CN), Liaoning Cancer Hospital & Institute (CN)
Good health and well-being
Openalex Percentile: Top 26%
Esophageal Cancer Research and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.